About

DSEC is a peer membership of 2,000 drug safety leaders with the common objective of advancing the development of better and safer medicines. Membership is limited to employees of companies developing small and large molecule pharmaceuticals. DSEC also manages a Technology Evaluation Consortium that qualifies novel, preclinical safety platforms.  DSEC is owned and operated by Cambridge Healthtech Associates (CHA).  Learn more at www.drugsafetycouncil.org or www.chacorporate.com